Literature DB >> 11187965

Neuroinvasion of prions: insights from mouse models.

S Brandner1, M A Klein, R Frigg, V Pekarik, P Parizek, A Raeber, M Glatzel, P Schwarz, T Rülicke, C Weissmann, A Aguzzi.   

Abstract

The prion was defined by Stanley B. Prusiner as the infectious agent that causes transmissible spongiform encephalopathies. A pathological protein accumulating in the brain of scrapie-infected hamsters was isolated in 1982 and termed prion protein (PrPSc). Its cognate gene Prnp was identified more than a decade ago by Charles Weissmann, and shown to encode the host protein PrP(C). Since the latter discovery, transgenic mice have contributed many important insights into the field of prion biology, including the understanding of the molecular basis of the species barrier for prions. By disrupting the Prnp gene, it was shown that an organism that lacks PrP(C) is resistant to infection by prions. Introduction of mutant PrP genes into PrP-deficient mice was used to investigate the structure-activity relationship of the PrP gene with regard to scrapie susceptibility. Ectopic expression of PrP in PrP knockout mice proved a useful tool for the identification of host cells competent for prion replication. Finally, the availability of PrP knockout mice and transgenic mice overexpressing PrP allows selective reconstitution experiments aimed at expressing PrP in neurografts or in specific populations of haemato- and lymphopoietic cells. The latter studies have allowed us to clarify some of the mechanisms of prion spread and disease pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11187965     DOI: 10.1111/j.1469-445x.2000.02091.x

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  8 in total

1.  The normal cellular prion protein (PrPc) is strongly expressed in bovine endocrine pancreas.

Authors:  W M Amselgruber; M Büttner; T Schlegel; M Schweiger; E Pfaff
Journal:  Histochem Cell Biol       Date:  2005-10-06       Impact factor: 4.304

Review 2.  Implications of peptide assemblies in amyloid diseases.

Authors:  Pu Chun Ke; Marc-Antonie Sani; Feng Ding; Aleksandr Kakinen; Ibrahim Javed; Frances Separovic; Thomas P Davis; Raffaele Mezzenga
Journal:  Chem Soc Rev       Date:  2017-10-30       Impact factor: 54.564

3.  Initial fate of prions upon peripheral infection: half-life, distribution, clearance, and tissue uptake.

Authors:  Akihiko Urayama; Rodrigo Morales; Michael L Niehoff; William A Banks; Claudio Soto
Journal:  FASEB J       Date:  2011-05-09       Impact factor: 5.191

Review 4.  Transgenic mouse models of neurodegenerative disease: opportunities for therapeutic development.

Authors:  Joanna L Jankowsky; Alena Savonenko; Gabriele Schilling; Jiou Wang; Guilian Xu; David R Borchelt
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

5.  Normal cellular prion protein protects against manganese-induced oxidative stress and apoptotic cell death.

Authors:  Christopher J Choi; Vellareddy Anantharam; Nathan J Saetveit; Robert S Houk; Arthi Kanthasamy; Anumantha G Kanthasamy
Journal:  Toxicol Sci       Date:  2007-05-04       Impact factor: 4.849

Review 6.  Successes and challenges in phenotype-based lead discovery for prion diseases.

Authors:  Sina Ghaemmaghami; Miranda Russo; Adam R Renslo
Journal:  J Med Chem       Date:  2014-04-24       Impact factor: 7.446

7.  Glial activation in prion diseases is selectively triggered by neuronal PrPSc.

Authors:  Asvin K K Lakkaraju; Silvia Sorce; Assunta Senatore; Mario Nuvolone; Jingjing Guo; Petra Schwarz; Rita Moos; Pawel Pelczar; Adriano Aguzzi
Journal:  Brain Pathol       Date:  2022-02-17       Impact factor: 7.611

Review 8.  Therapeutic Potential of Bee and Scorpion Venom Phospholipase A2 (PLA2): A Narrative Review.

Authors:  Parisa Soltan-Alinejad; Hamzeh Alipour; Davood Meharabani; Kourosh Azizi
Journal:  Iran J Med Sci       Date:  2022-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.